Company profile
Pattern BioSciences AG
Pattern BioSciences is an early stage biotechnology start up company and an ETH Zurich spin-off. The company develops programmable cancer gene therapies using gene circuit technologies.
Source: startup.ch
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". Register for more services
Partners
Contributors
